​

NeuroSense Therapeutics Ownership | Who Owns NeuroSense Therapeutics?

OverviewChart

NeuroSense Therapeutics Ownership Summary

NeuroSense Therapeutics is owned by 0.59% institutional investors, 32.31% insiders, and 67.11% retail investors. Yorkville advisors global, lp is the largest institutional shareholder, holding 0.31% of NRSN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in NeuroSense Therapeutics shares.

NRSN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeuroSense Therapeutics0.59%32.31%67.11%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Yorkville advisors global, lp78.00K0.31%$58.89K
Independent advisor alliance50.00K0.20%$37.75K
Ubs group49.10K0.19%$37.07K
Two sigma investments, lp44.45K0.17%$33.56K
Meitav investment house40.00K0.16%$30.20K
Jane street group28.67K0.11%$21.65K
Commonwealth equity services22.77K0.09%$17.19K
Pnc financial services group21.15K0.08%$15.97K
Pathstone16.53K0.06%$12.48K
Geode capital management15.87K0.06%$11.98K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Yorkville advisors global, lp78.00K0.04%$58.89K
Independent advisor alliance50.00K0.00%$37.75K
Meitav investment house40.00K0.00%$30.20K
Commonwealth equity services22.77K-$17.19K
Marshall wace, llp---
Cwm---
Jane street group28.67K-$21.65K
Two sigma securities---
Cantor fitzgerald, l. p.---
Renaissance---

Top Buyers

HolderShares% AssetsChange
Independent advisor alliance50.00K0.00%50.00K
Jane street group28.67K-28.67K
Pnc financial services group21.15K-21.15K
Ubs group49.10K-18.23K
Meitav investment house40.00K0.00%-

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.58M
Cantor fitzgerald, l. p.---79.49K
Renaissance---71.10K
Morgan stanley---66.40K
Gts securities---35.75K

New Positions

HolderShares% AssetsChangeValue
Independent advisor alliance50.00K0.00%50.00K$37.75K
Jane street group28.67K-28.67K$21.65K
Pnc financial services group21.15K-21.15K$15.97K

Sold Out

HolderChange
Qube research-54.00
Jessup wealth management-500.00
Total investment management-500.00
Cwm-1.00K
Hurley capital-6.53K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20266-53.85%149,814-56.72%-31.67%2-75.00%1-
Dec 31, 202510-281,6781.35%192.63%6100.00%1-66.67%
Sep 30, 202510-37.50%277,925-38.24%125.32%3-72.73%350.00%
Jun 30, 20251536.36%449,544130.66%2294.96%10233.33%2-33.33%
Mar 31, 202511-15.38%194,892-69.85%-6.54%3-70.00%3200.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index15.87K0.04%-

Insider Transactions Trends

DateBuySell
2026 Q1--
2024 Q3--
2023 Q1--
2022 Q4--
2022 Q1--

NRSN Ownership FAQ

Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics shareholders are primarily institutional investors at 0.59%, followed by 32.31% insiders and 67.10% retail investors. The average institutional ownership in NeuroSense Therapeutics's industry, Biotech Stocks , is 35.75%, which NeuroSense Therapeutics falls below.

Who owns the most shares of NeuroSense Therapeutics?

NeuroSense Therapeutics’s largest shareholders are Yorkville advisors global, lp (78K shares, 0.31%), Independent advisor alliance (50K shares, 0.20%), and Ubs group (49.1K shares, 0.19%). Together, they hold 0.69% of NeuroSense Therapeutics’s total shares outstanding.

Does Blackrock own NeuroSense Therapeutics?

BlackRock is not among the top 10 institutional shareholders of NeuroSense Therapeutics.

Who is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested?

Yorkville advisors global, lp is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 78K NeuroSense Therapeutics shares, valued at 58.89K$.

Who is the top mutual fund holder of NeuroSense Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of NeuroSense Therapeutics shares, with 0.04% of its total shares outstanding invested in 15.87K NeuroSense Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools